Christ-Crain, Mirjam
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
Swiss National Science Foundation
Project funding, Effects of the SGLT2 inhibitor empagliflozin in patients with euvolemic and hypervolemic hyponatremia – a multicentric randomized double-blind placebo-controlled trial - the EMPOWER Study, 212282, 2022–2026, 1 Oct 2022
Sources: openalex.org